NCT02041676

Brief Summary

The main objective is to show by a randomised controled therapeutic trial comparing in two parallel open arms ( 50 infants x 2 = 100 infants) that the technique IIF decreases the duration of non invasive respiratory support in the group treated by chest physiotherapy as compared to the control group. The secondary objectives are to evaluate the duration of oxygen dependence, the duration of hospitalisation and the proportional advent of bronchopulmonary dysplasia. These study will be conducted in patients less than 32 weeks post menstrual age, eutrophic, treated by non invasive respiratory support after weaning off from mechanical endotracheal ventilation benefitting form a social security system and for whom the appropriate parental authority are non opposed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 22, 2014

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2017

Completed
Last Updated

May 5, 2017

Status Verified

April 1, 2017

Enrollment Period

3.2 years

First QC Date

January 20, 2014

Last Update Submit

May 2, 2017

Conditions

Keywords

ChestPhysiotherapyIncreased Inspiratory Flow TechniquePrematurityNon Invasive Ventilation

Outcome Measures

Primary Outcomes (1)

  • Number of days of non invasive respiratory support post extubation

    Data noted till discharge from special care (baby ) unit (4 months)

Secondary Outcomes (4)

  • Duration of oxygen dependence.

    Data noted till discharge from special care (baby ) unit (4 months)

  • Duration of hospitalisation of the premature infant on the special care unit

    4 months

  • bronchopulmonary dysplasia as established by the WALSH test as well as the presence of atelectasis on the chest X ray done within the 7 days following extubation

    at 36 weeks post menstrual age

  • Pain score realised during the session

    until 4 months

Study Arms (2)

1: chest physiotherapy technique

EXPERIMENTAL

Chest physiotherapy technique increasing inspiratory flow (IIF) 3 times per day

Procedure: Chest physiotherapy

2: Usual surveillance

ACTIVE COMPARATOR

Usual surveillance of the non invasive ventilation

Procedure: Usual surveillance

Interventions

Also known as: Increased inspiratory flow technique (IIF)
1: chest physiotherapy technique

Usual surveillance of the non invasive ventilation without chest physiotherapy.

2: Usual surveillance

Eligibility Criteria

Age24 Weeks - 32 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants \< 32 weeks post menstrual age (corrected gestational age) and eutrophic on the AUDIPOG charts
  • Patients with non invasive ventilation/ respiratory support following weaning from mechanical endo tracheal ventilation.
  • Information letter given to the appropriate parental authority.
  • Prior medical evaluation.
  • Affiliation with a social security system.

You may not qualify if:

  • Pneumothorax, emphysema, reintubation within 24 hours.
  • Small for gestational age as defined by a birth weight \< 10th percentile on the AUDIPOG charts.
  • Intraventricular hemorrhage grade 3 and 4 (VOLPE's classification- (32-33))
  • Thrombopenia (Platelet count \< 80 000/mm3)
  • Malformative syndromes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AP-HP, Antoine Béclère Hospital

Clamart, 92141, France

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome, NewbornPremature Birth

Condition Hierarchy (Ancestors)

Respiratory Distress SyndromeLung DiseasesRespiratory Tract DiseasesRespiration DisordersInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Bruno Demont

    Assistance Publique - Hôpitaux de Paris

    STUDY CHAIR
  • Camille Roussel, MD

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2014

First Posted

January 22, 2014

Study Start

January 1, 2014

Primary Completion

April 1, 2017

Study Completion

April 1, 2017

Last Updated

May 5, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations